AGN News 163.65 04/22/2014 17:17:46 Allergan Inc (AGN)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Allergan Inc (AGN) 163.65 $AGN

NYSE stocks posting largest volume increases
AP - 15 mins ago
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:

NYSE stocks posting largest percentage increases
AP - 15 mins ago
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:

Most active New York Stock Exchange-traded stocks
AP - 14 mins ago
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:

Why GW Pharmaceuticals, Revance Therapeutics, and Allergan Are Today's 3 Best Stocks
Sean Williams, The Motley Fool - Motley Fool - 1 hr 2 mins ago
The health-care sector may have been a major crutch for the broad-based S&P 500 during the past two months, but today it was its greatest savior, with merger and acquisition activity galore driving the index to the upside. Also helping...

Stocks Rise In Higher Volume; Gilead Up After Hours
at Investor's Business Daily - 1 hr 2 mins ago
Stocks rose in higher volume Tuesday, with the Nasdaq and S&P 500 notching their sixth straight gains amid a flurry of buyout activity in the drugs industry. The Nasdaq rose 1%, while the S&P 500 and the Dow Jones industrial average each rose 0.4%....

Netflix and Harley-Davidson are big market movers
AP - 1 hr 18 mins ago
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:

S&P 500, Nasdaq Rise For Sixth Day As Volume Picks Up
at Investor's Business Daily - 1 hr 48 mins ago
Stocks surged in higher volume Tuesday, with the Nasdaq and the S&P 500 rising for a sixth consecutive day, amid strength in drug stocks. The Nasdaq rose 1% while the S&P 500 and Dow Jones industrial average gained 0.4% each. Volume was sharply...

Stocks Flirt With All-Time Highs on Earnings, Deals News
at The Street - 2 hrs ago
U.S. stocks climb Tuesday amid headlines on pharmaceutical deals and better-than-expected existing-home sales.

Why Allergan Inc. Shares Skyrocketed
Sean Williams, The Motley Fool - Motley Fool - Tue Apr 22, 2:00PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Allergan , a global integrated-health-care...

2 Biotech Stocks to Trade (or Not)
at The Street - Tue Apr 22, 12:37PM CDT
Here's a look at how to trade some of the most active stocks on the market today.

Pershing Square and Valeant's Allergan Deal a Watershed for Activism
at The Street - Tue Apr 22, 12:36PM CDT
Pershing Square Capital Management may be re-writing the rules of activist investing after teaming up with Valeant Pharmaceuticals on a potential takeover of Allergan.

Nasdaq, Health Care Lead Stock Market Higher
at Investor's Business Daily - Tue Apr 22, 12:32PM CDT
The Nasdaq and medical stocks led a market surge Tuesday afternoon. The composite was up more than 1% while the S&P 500 and Dow Jones industrial average gained 0.6% each. Volume was sharply higher across the board. Winning stock led losers by 3-to-1...

Will Idera Pharmaceuticals (IDRA) Stock Sustain Today's Rally?
at The Street - Tue Apr 22, 12:21PM CDT
Idera Pharmaceuticals (IDRA) surged Tuesday on a positive day for healthcare stocks after the company had remained relatively flat since last week.

Valeant Bid For Allergan Draws Mixed Reaction
at Investor's Business Daily - Tue Apr 22, 11:44AM CDT
Valeant Pharmaceuticals (VRX) and hedge fund Pershing Square early Tuesday officially announced an unsolicited takeover bid for Allergan (AGN) that values the Botox-maker at more than $47 billion. News of the pending deal broke late Monday, but in a...

Indexes Extend Gains Amid Upside Earnings Surprises
at Investor's Business Daily - Tue Apr 22, 11:29AM CDT
The major averages extended their gains in midday trade as stocks rallied, helped by upside earnings surprises and Allergan 's (AGN) buyout news. The Nasdaq led with a 1% gain, while the S&P 500 and the Dow industrials each rose 0.6%. Volume was...

Allergan: Here's Why Ackman and Valeant Want the Botox Maker
Todd Campbell, The Motley Fool - Motley Fool - Tue Apr 22, 11:00AM CDT
Weeks after Johnson & Johnson  shelved plans to launch a Botox competitor, Allergan is in the news again. Hedge fund manager Bill Ackman's Pershing Square has built a nearly 10% stake in Allergan in advance of a potential $45 billion bid by...

5 Stories You Can't Miss About Big Pharma, Facebook: StockTwits
at The Street - Tue Apr 22, 10:33AM CDT
These stories are generating a ton of social interest and heated debate. Make sure to chime in.

Valeant, Ackman Join Forces in $45B Allergan Bid
at The Street - Tue Apr 22, 10:31AM CDT
Offer is activist's first hostile acquisition partnership; Pershing commits $400 million to the deal.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

RingConn Bets Middle-earth Fandom Can Boost Health Wearables

Updated Category News Views 102

A Familiar Gold Band Meets a Crowded Wearables Market RingConn has taken one of pop culture's most loaded objects and turned it into a health-tracking accessory, which is either clever brand work or a costly bit of cosplay depending on execution. The company unveiled The One Ring, a limited-edition version of its Gen 3 Smart Ring, through a partnership with Warner Bros....

Continue Reading
GEYOTO’s RE+ Debut Shows Demand, Not Yet Scale Proof

Updated Category News Views 39

Desert-colored booths do not pay invoices, but a nearly sold-out stash of spare units is a lot more useful than the usual trade-show applause. GEYOTO’s first RE+ appearance, held November 17–19 at the Las Vegas Convention Center, produced the kind of early evidence a young energy-products brand needs: people stopped, handled the equipment, asked questions, made...

Continue Reading
Workers Are Burning Savings as Pay Falls Behind Costs

Updated Category News Views 69

Payroll optimism has been ground into dust by the ordinary bills nobody can dodge. Monster's 2026 Cost of Living Report says 93% of employed U.S. workers feel their wages are failing to keep up with costs, barely different from 95% in both 2024 and 2025. That is not a blip, and it is not workers merely grousing about prices. Three years of nearly identical frustration...

Continue Reading
Mars Sets $2 Billion Debt Tender With Kellanova Notes

Updated Category News Views 108

A two-billion-dollar vacuum cleaner just switched on inside Mars’s debt stack, and the timing is anything but casual. On November 20, Mars fixed the pricing for cash tender offers spanning selected Mars and Kellanova senior notes, with holders facing a 5:00 p.m. New York deadline that same day. This is the kind of filing that looks like bond-market plumbing until you...

Continue Reading
Central Florida Buyers Face the Cash Reality First

Updated Category News Views 109

A house hunt can go sideways before the first showing if the buyer has confused a dream budget with a real one. Tom McKnight’s guidance for first-time buyers in Central Florida lands on the unglamorous stuff, which is exactly where it ought to land: cash, credit, financing, insurance, taxes, and the physical condition of the house. Nobody enjoys staring at lender...

Continue Reading
CVRx Lawsuit Puts Barostim Sales Claims Under Hard Scrutiny

Updated Category News Views 109

August 7 turned a compliance disclosure into a wrecking ball for CVRx shareholders. After the company revealed a Department of Justice civil investigative demand and cut its outlook, the stock dropped $3.55, or 60%, to close at $2.39. That is not a routine bad quarter getting punished. It is the market abruptly questioning whether the sales engine, the revenue it...

Continue Reading
KONST Pitches Asia GPU Uptime as AI Demand Gets Real

Updated Category News Views 115

GPU racks are easy to admire when the lights are on; keeping them useful at 3 a.m. is where the bruises show. KONST arrived at SC26 in Chicago with a sensible pitch for an AI-infrastructure market that is getting less impressed by shiny hardware lists and more obsessed with whether the thing actually works. Its theme, “24/7 GPUs Delivered in Asia,” puts the emphasis...

Continue Reading
Why Brief Chiropractic Visits Still Need Clear Expectations

Updated Category News Views 97

A few minutes on the table can sound almost suspiciously brisk when somebody is dealing with a stiff neck, sore back, or nagging joint discomfort. Yet that is the central point in Dr. Craig Peterson's explanation for HelloNation: the adjustment itself may be brief, while the value of a chiropractor visit depends on a focused assessment, appropriate technique, and whether...

Continue Reading
PayPal's New Leadership Map Puts Execution on Trial

Updated Category News Views 106

Four senior appointments and a risk-chief exit can turn a tidy strategy slide into a very real operating test. PayPal has spent months defining three-year plans, simplifying its operating model and assigning clearer accountability; on November 20, it put names beside the jobs. For NASDAQ:PYPL investors, that is more consequential than another broad promise about...

Continue Reading
CVRx Lawsuit Puts a Hard Date on Investor Decisions

Updated Category News Views 65

One ugly filing after the bell can vaporize years of shareholder confidence, and CVRx just supplied the painful exhibit. On August 7, 2026, shares of CVRx fell $3.55, or 59.76%, to close at $2.39 after the company disclosed a U.S. Department of Justice civil investigative demand in its August 6 Form 10-Q. That is not a routine bad quarter. It is the sort of disclosure...

Continue Reading

Top 5 Most Recently Viewed Articles

Ready Capital Corporation's 2024 Results Overview & Future Insights

Updated Category News Views 176

Ready Capital Corporation's Upcoming Financial Results Ready Capital Corporation (NASDAQ: RC) is poised to share its financial results for the fourth quarter and the full year of 2024. This significant announcement is expected to take place before the opening bell of the New York Stock Exchange on the designated release date. Investors and interested parties are eagerly...

Continue Reading
Nano-X Faces Securities Suit, Investors Alerted

Updated Category News Views 32

Legal Tsunami Hits Nano-X Imaging If there’s one thing that makes investors' hairs stand on end, it’s the words 'class action lawsuit.' And now, it's swirling around Nano-X Imaging Ltd. (NASDAQ: NNOX) like a tempest. The DJS Law Group has taken the lead, lighting the legal torches on claims that Nano-X fed investors a cocktail of misleading statements regarding its...

Continue Reading
Novo Nordisk A/S Shareholders: Take Action on Recent Allegations

Updated Category News Views 218

Understanding the Novo Nordisk A/S Class Action Opportunity Recent developments have led to significant scrutiny of Novo Nordisk A/S, a major player in the pharmaceutical industry. For shareholders, this highlights a crucial opportunity to engage in a class action lawsuit regarding alleged misleading statements about the company's CagriSema weight loss study results....

Continue Reading
Investors of Inspire Medical Systems Should Act Before Deadline

Updated Category News Views 288

Important Deadline for Inspire Medical Systems Investors Investors of Inspire Medical Systems, Inc. are reminded that a critical deadline is approaching for those who purchased securities. The firm Kirby McInerney LLP has encouraged investors to take action as they seek the lead plaintiff role in a federal securities class action. About the Legal Proceedings This lawsuit...

Continue Reading
Nicholas Wealth's Impressive $GIAX Distribution Yield Announcement

Updated Category News Views 88

Recent Announcement from Nicholas Wealth Management Nicholas Wealth, renowned for its commitment to delivering actively managed income ETFs, has made an exciting announcement regarding its latest distribution. The Nicholas Global Equity and Income ETF (GIAX) will offer investors a substantial monthly distribution yield of an impressive 24.00%. This announcement is...

Continue Reading